Study of Mouse Colon Cancer Cells in Different Body Sites
Author Information
Author(s): F. Vidal-Vanaclochal, D. Glaves, E. Barbera-Guilleml, L. Weiss
Primary Institution: University of the Basque Country; Roswell Park Cancer Institute
Hypothesis
How does the expression of endogenous lectins in mouse colon 26 carcinoma cells vary in different metastatic sites?
Conclusion
The study found significant differences in endogenous lectin expression in cancer cells depending on their metastatic site.
Supporting Evidence
- Endogenous lectins were visualized using a panel of 17 biotinylated neoglycoproteins.
- Significant differences in lectin expression were detected in at least four sites for all neoglycoproteins.
- Complex patterns of reactivities were observed with the neoglycoproteins in different sites.
Takeaway
The study looked at how cancer cells from mouse colon tumors behave differently depending on where they grow in the body.
Methodology
Quantitative microdensitometry and image analysis were used to assess lectin expression in cancer cells from various sites.
Potential Biases
Potential bias in the selection of neoglycoproteins and the interpretation of staining results.
Limitations
The study did not provide detailed numerical data for all measurements.
Participant Demographics
Balb/c female mice aged 6 to 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website